Healthcare -
Biotechnology - NASDAQ - US
$ 0.6594
0.687 %
$ 2.44 M
Market Cap
-0.14
P/E
PCSA - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities PCSA - Processa Pharmaceuticals, Inc.
6.27 M
LAST VALUE
-20.02%
2 YEAR CAGR
19.03%
5 YEAR CAGR
13.73%
10 YEAR CAGR